NCT03893799View on ClinicalTrials.gov

A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

April 22, 2020

Study Completion Date

December 31, 2020

Conditions
Healthy VolunteersChronic Kidney Disease
Interventions
DRUG

RBT-1

Single intravenous administration

Trial Locations (1)

32141

Riverside Clinical Research, Edgewater

All Listed Sponsors
lead

Renibus Therapeutics, Inc.

INDUSTRY

NCT03893799 - A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease | Biotech Hunter | Biotech Hunter